2024-11-20 11:26:38
Innovent and Lilly Release Phase 3 Results of TYVYT® (Sintilimab Injection) as a Second-Line Treatment for Squamous Non-Small Cell Lung Cancer at AACR Annual Meeting 2021
Corporate/ 2023-07-23
Innovent and Lilly Release Phase 3 Resul...

SAN FRANCISCO and SUZHOU,China,April 13,2021-- Innovent Biologics,Inc. ("Innovent",HKEX: 01801),a world-class biopharmaceutical co...

Alphamab Oncology Presented Clinical Data of KN046 Combined with Nab-paclitaxel in the Treatment of mTNBC at AACR 2021
Corporate/ 2023-07-23
Alphamab Oncology Presented Clinical Dat...

SUZHOU,China,April 13,2021-- Alphamab Oncology (stock code: 9966.HK) announced that data from phase Ib/II clinical study (clinical trial No....

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release